In vitro in vivo relations for the parenteral liposomal formulation of Amphotericin B: A biorelevant and clinically relevant approach-Reference-Cited by-同舟云学术

In vitro in vivo relations for the parenteral liposomal formulation of Amphotericin B: A biorelevant and clinically relevant approach

Published:2021-02 Issue: Volume:159 Page:188-197
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Díaz de León–Ortega R.,D'Arcy D.M.,Lamprou D.A.,Xue W.F.,Fotaki N.

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference39 articles.

1. Liposome: classification, preparation, and applications;Akbarzadeh;Nanoscale Res. Lett.,2013

2. Performance test for parenteral dosage forms;Shah;Dissolution Technol.,2015

3. FDA, Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation, 2005. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070570.pdf. (access date: 31/07/2019).

4. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes;Panwar;Int. J. Nanomed.,2010

5. Influence of cholesterol on liposome stability and on in vitro drug release;Briuglia;Drug Delivery Trans. Res.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of subcutaneous drug absorption − Development of novel simulated interstitial fluid media for predictive subcutaneous in vitro assays;International Journal of Pharmaceutics;2024-06

2. Revisiting the in-vitro and in-vivo considerations for in-silico modelling of complex injectable drug products;Journal of Controlled Release;2023-08

3. In Silico Modeling Approaches Coupled with In Vitro Characterization in Predicting In Vivo Performance of Drug Delivery System Formulations;Molecular Pharmaceutics;2023-07-31

4. In vitro antibacterial activity and in vivo pharmacokinetics of intravenously administered Amikacin-loaded Liposomes for the management of bacterial septicaemia;Colloids and Surfaces B: Biointerfaces;2022-12

5. Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical data;International Journal of Pharmaceutics;2021-10